Cargando…
Can VA-ECMO Be Used as an Adequate Treatment in Massive Pulmonary Embolism?
Introduction: Massive acute pulmonary embolism (MAPE) with obstructive cardiogenic shock is associated with a mortality rate of more than 50%. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used in refractory cardiogenic shock with very good results. In MAPE, althou...
Autores principales: | Giraud, Raphaël, Laurencet, Matthieu, Assouline, Benjamin, De Charrière, Amandine, Banfi, Carlo, Bendjelid, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348430/ https://www.ncbi.nlm.nih.gov/pubmed/34362159 http://dx.doi.org/10.3390/jcm10153376 |
Ejemplares similares
-
ECMO in Cardiac Arrest: A Narrative Review of the Literature
por: De Charrière, Amandine, et al.
Publicado: (2021) -
The use of extracorporeal CO(2) removal in acute respiratory failure
por: Giraud, Raphaël, et al.
Publicado: (2021) -
Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients
por: Giraud, Raphaël, et al.
Publicado: (2021) -
Management of High-Risk Pulmonary Embolism: What Is the Place of Extracorporeal Membrane Oxygenation?
por: Assouline, Benjamin, et al.
Publicado: (2022) -
A Dedicated Expert ECMO-Team and Strict Patient Selection Improve Survival of Patients with Severe SARS-CoV-2 ARDS Supported by VV-ECMO
por: Giraud, Raphaël, et al.
Publicado: (2022)